Info Oyx
FIGURE 6.8 Apparent simple competitive antagonism of carbachol-induced contraction of guinea pig trachea through physiological antagonism of tracheal contractile mechanisms by b-adrenoceptor relaxation of the muscle. a Schematic diagram of the physiological interaction of the muscarinic receptor-induced contraction and b-adrenoceptor-induced relaxation of tracheal tissue. b Schild regression for isoproterenol b-adrenoceptor agonist antagonism of carbachol-induced contraction. The regression is...
Info Rgi
FIGURE 8.25 Repeated oral administration of drugs leads to steady-state plasma concentrations. If elimination is rapid and administration not often enough, then an elevated and therapeutically effective steady-state concentration may not be achieved green lines . In contrast, if elimination is very slow or administration too often , then an accumulation of the drug may be observed with no constant steady state red line . Blue line shows a correct balance between frequency of administration and...
Info Emp
FIGURE 11.23 Power analysis.The desired difference is gt 2 standard deviation units l C 8 . The sample distribution in panel a is wide and only 67 of the distribution values are gt 8. Therefore, with an experimental design that yields the sample distribution shown in panel a will have a power of 67 to attain the desired endpoint. In contrast, the sample distribution shown in panel b is much less broad and 97 of the area under the distribution curve is gt 8. Therefore, an experimental design...
Info Tnm
FIGURE 5.6 Calcitonin receptor responses. a Real-time melanin dispersion reduced light transmittance caused by agonist activation with human calcitonin of transfected human calcitonin receptors type II in melanophores. Responses to 0.1 nM filled circles and 10 nM open circles human calcitonin. c Dose-response curves to calcitonin in melanophores open circles and HEK 293 cells, indicating calcium transient responses filled circles . FIGURE 5.7 Internalization of GPCRs. a Receptors adopt an...
Info Knk
FIGURE 9.17 Venn diagram consisting of the various possible activities agonism and antagonism on two receptor subtypes a- and b-adrenoceptors . Letters label the areas of intersection denoting joint activity. The table shows possible therapeutic application of such joint activity. FIGURE 9.17 Venn diagram consisting of the various possible activities agonism and antagonism on two receptor subtypes a- and b-adrenoceptors . Letters label the areas of intersection denoting joint activity. The...
Info Hra
Nort-cowpaitoVe ncepfor or flosteric FIGURE 12.2 Displacement of a radioligand by a nonradioactive competitive ligand. Ligand displaces signal to nsb, which in this case is 15 pmoles mg protein. Ordinates pmoles mg protein bound. Abscissae concentration of displacing ligand in pM on a logarithmic scale. a Data for displacement curves shown for increasing concentrations of radioligand. Curves shown for A Kd 0.1 filled circles , A Kd 0.3 open circles , A Kd 1.0 filled squares , and A Kd 3.0 open...
Info Soi
FIGURE 6.22 Pharmacological, resultant analysis of atropine. Panels a through d dose-response curves to carbachol in the absence filled circles and presence of various concentrations of the reference antagonist scopolamine. a Scopolamine 1 nM open diamonds , 3nM filled triangles , 10 nM open inverted triangles , and 30 nM filled squares . b As for a, except experiment carried out in the presence of 3nM atropine. Conc of scopolamine 3 nM, 10 nM, 30 nM, and 100 nM. Dotted line shows control curve...
Br Mrw
Ka Equilibrium dissociation constant of agonist-receptor complex. Kb Equilibrium dissociation constant of antagonist-receptor complex. T transducer function for response to the full agonist. FIGURE 10.22 Figure illustrating the effects of an orthosteric noncompetitive antagonist on concentration-response curves to a full agonist. Equations describe response in terms of the operational model variable slope version equation derived in Section 10.6.7 . Schematic indicates the interacting species...
Info Oap
used to resolve whether the data is better fit to a single curve indicating noise around the control curve and no antagonism or to two separate curves antagonist produces a low level of receptor blockade . For the data shown in Figure 11.16, the value for F indicated that a statistically significant improvement in the fit was obtained with two dose-response curves as opposed to one. This indicates, in turn, that the antagonist had an effect at this concentration. 11.4.7 Asymmetrical...
Ec50
This leads to the logarithmic metameter form of the Schild equation 7.8.4 Relationship of pA2 and pKBfor Insurmountable Allosteric Antagonism As with insurmountable orthosteric antagonists, the shift to the right of concentration-response curves produced by allosteric insurmountable antagonists can be used to calculate a pA2 value, and in turn this can be related to the pKB of the antagonist. A concentration of antagonist equal to the pA2 i.e., concentration 10 pA2 causes a dose ratio of 2,...
Info Mhz
0.001 0.01 0.1 1.0 10 100 1000 B KB log scale 0.01 0.1 1.0 10 100 1000 B KB log scale 0.01 0.1 1.0 10 100 1000 B KB log scale FIGURE 7.17 Effect of varying allosteric effects on agonist affinity on the ratio of the IC50 to the true KB. Graph A shows the effects of a modulator that decreases the affinity of the receptor for the agonist inset panel a for a 0.01 . Shown are inhibition curves in the presence of increasing concentrations of agonist. These shift the inhibition curves to the right and...
Info Lbw
FIGURE 1.15 Dose-response curves. Dose-response curve to an agonist that produces 80 of the system maximal response. The EC50 concentration producing 40 response is 1 M, the EC25 20 is 0.5 M and the EC80 64 is 5 M. required to produce 50 of the maximal response to the agonist. Thus, an EC50 value of 1 mM indicates that 50 of the maximal response to the agonist is produced by a concentration of 1 mM of the agonist Figure 1.15 . If the agonist produces a maximal response of 80 of the system...
E
where KE is the fitting parameter for the hyperbolic response. However, KE also has a pharmacological meaning as well in that it is the concentration of AR complex that produces half the maximal response. It also defines the ease with which the agonist produces response i.e., it is a transduction constant . The more efficient the process from production to AR to response the smaller is KE. Combining Equations 3.43 and 3.44 yields the quintessential equation for the operational model A very...
abc
0 100 200 msec 0 100 200 msec 0 100 200 msec Log isoproterenol Log prenalterol FIGURE 2.18 Inotropic and lusitropic responses of guinea pig left atria to P-adrenoceptor stimulation. Panels A to C isometric tension waveforms of cardiac contraction ordinates are mg tension abscissae are msec . a Effect of 0.3 nM isoproterenol on the waveform. The wave is shortened due to an increase in the rate of diastolic relaxation, whereas no inotropic response change in peak tension is observed at this...
[A [ KbKA KBK
where a regression of A' A upon A0 yields a straight line, with the KB being equal to Figure 6.18 shows the procedure for using this method. In terms of the practical application, an important point to note is that the maximal response to the agonist must be depressed by the noncompetitive antagonist for this method to be effective. In fact, the greater the degree of maximal response inhibition the more robust is the fit according to Equation 6.33. Moreover, data points at the concentrations of...
Response Curves
Figure 1.12 . At first glance, the shapes of dose-response curves appear to closely mimic the line predicted by the Langmuir adsorption isotherm and it is tempting to assume that dose-response curves reflect the first-order binding and activation of receptors on the cell surface. However, in most cases this resemblance is happenstance and dose-response curves reflect a far more complex amalgam of binding, activation, and recruitment of cellular elements of response. In the end, these may yield...